RB
Retro Biosciences
Resolving
Resolving brand mentions across new media
Retro Biosciences
Resolving brand mentions across new media
Retro Biosciences
Arcmira media summary
Browse Retro Biosciences interviews, podcasts & event videos — 11 indexed from Core Memory Podcast & CNN, updated May 2026.
A longevity startup Sam Altman invested in that focuses on cellular reprogramming.
Longevity biotech company mentioned as being backed by Sam Altman.
Biotechnology company focused on adding 10 years of healthy human lifespan through cellular reprogramming and other modalities.
CEO of Retro Biosciences recently freshly funded, started in 2021.
Biotech company that partnered with OpenAI to test AI-designed proteins for rejuvenation.
Arcmira tracks 11 indexed media appearances or mentions for Retro Biosciences, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "OpenAI's Sam Altman trusts AI will treat most diseases by 2035" with transcript-derived context and links when available.
Retro Biosciences is connected to Stargate, Longevity, GLP-1 in Arcmira's media graph.
11
Mentions
457.8K
Views
The trendline is visible, but the dated evidence behind Retro Biosciences is in the premium layer.
“A longevity startup Sam Altman invested in that focuses on cellular reprogramming.”
“Longevity biotech company mentioned as being backed by Sam Altman.”
“Biotechnology company focused on adding 10 years of healthy human lifespan through cellular reprogramming and other modalities.”
“CEO of Retro Biosciences recently freshly funded, started in 2021.”
“Biotech company that partnered with OpenAI to test AI-designed proteins for rejuvenation.”